We can't find the internet
Attempting to reconnect
19310.1 PFLS-LS
19310.1 PFLS-LS
Zusammenfassung
Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia
Weitere Texte
Abstract
To develop novel peptide drug conjugates that target a newly identified cancer marker overexpressed in multiple cancers. The project aims to create peptide drug conjugates for treating acute myeloid leukemia and obtain at least one drug candidate ready for further development. This will enable Phi Pharma to secure additional financing to prepare for the first clinical trial, and eventually enter into a significant collaboration with a major pharmaceutical company.
Beteiligte
Emmanuel Savioz
Wirtschaftspartner
emmanuel.savioz@phi-pharma.com
Phi Pharma Emmanuel Savioz Place du Midi 36 1950 Sion VS CH
Marc Mathieu
Kontaktperson
marc.mathieu@hevs.ch
HES-SO Valais-Wallis Marc Mathieu Route du Rawyl 64 1950 Sion VS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-09-30
- Enddatum
- 2018-04-30
- Bewilligte Gesamtkosten
- CHF 357830.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%